Skip to main content
Premium Trial:

Request an Annual Quote

Martha Trela, Timothy Mayleben, Maclyn McCarty, and Gregory Schiffman

Premium

Martha Trela has joined Affymetrix in a sales and marketing position. She comes to Affymetrix from Applied Biosystems, where she had served as vice president for worldwide marketing programs and communications.


Timothy Mayleben has joined the board of directors of Rubicon Genomics, replacing Richard Sloan, the Ann Arbor, Mich.-based company said last week. Most recently, he was COO and CFO of Esperion Therapeutics, which was recently acquired by Pfizer.


Maclyn McCarty, who co-discovered that genes consist of DNA, died on Jan. 2, Rockefeller University said last week. Together with Oswald Avery and Colin MacLeod, McCarty showed in the 1940s that DNA, not proteins, carry genetic information. McCarty received a Special Achievement in Medical Science award from the Lasker Foundation in 1994. He was 93.


Affymetrix CFO Gregory Schiffman was elected to the board of directors of Xenogen. He also will serve on the firm’s audit committee.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.